Number of Shares
10.51 Mil
Current Holdings Value*
$132.27 Mil
% of Portfolio
2.98%
Total Estimate Gain
$115.02 Mil
% of Total Estimate Gain
145.82%

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s ARS Pharmaceuticals Inc Holding Summary

As of 2025-03-31, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) held 10.51 Mil shares of ARS Pharmaceuticals Inc(SPRY), totaling $132.27 Mil. This investment constitutes 2.98% of their stock portfolio, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) now holds 10.71% of the outstanding ARS Pharmaceuticals Inc(SPRY) stock.

The initial trade took place in 2022Q4. And since then DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) has made 1 purchases of SPRY, at an average price of $7.12, for a total of 11.08 Mil shares. In addition, there have been 1 sales at an average price of $14.00 for 563,270.00 shares. Based on historical transaction data and SPRY's current price of $17.69, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s estimated gain on his SPRY holdings is $115.02 Mil, reflecting a 145.82% gain to date.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) SPRY ($17.69) Holding Chart

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) SPRY ($17.69) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1